Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Vitória B CattaniAdriana R Pohlmann

Abstract

The aim of this work was to investigate if the indomethacin ethyl ester (IndOEt) released from lipid-core nanocapsules (NC) is converted into indomethacin (IndOH) in the intestine lumen, intestine wall or after the particles reach the blood stream. NC-IndOEt had monomodal size distribution (242 nm; PDI 0.2) and zeta potential of -11 mV. The everted rat gut sac model showed IndOEt passage of 0.16 micromol m(-2) through the serosal fluid (30 min). From 15 to 120 min, the IndOEt concentrations in the tissue increased from 6.13 to 27.47 micromol m(-2). No IndOH was formed ex vivo. A fluorescent-NC formulation was used to determine the copolymer bioadhesion (0.012 micromol m(-2)). After NC-IndOEt oral administration to rats, IndOEt and IndOH were detected in the gastrointestinal tract (contents and tissues). In the tissues, the IndOEt concentrations decreased from 459 to 5 microg g(-1) after scrapping, demonstrating the NC mucoadhesion. In plasma (peripheric and portal vein), in spleen and liver, exclusively IndOH was detected. In conclusion, after oral dosing of NC-IndOEt, IndOEt is converted into IndOH in the intestinal lumen and wall before reaching the blood stream. The complexity of a living system was not predicted by the ex v...Continue Reading

References

Dec 1, 1990·The Journal of Pharmacy and Pharmacology·P JaniA T Florence
May 1, 1997·Pharmaceutical Research·N HussainA T Florence
Aug 28, 1998·The Journal of Pharmacy and Pharmacology·J LimpanussornA D Dayan
May 5, 1999·Fundamental & Clinical Pharmacology·L BartheG Houin
Jun 11, 1999·International Journal of Pharmaceutics·B Carreno-GómezA T Florence
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·C A SantosE Mathiowitz
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K S SoppimathW E Rudzinski
Sep 29, 2001·Advanced Drug Delivery Reviews·A T Florence, N Hussain
Jan 5, 2002·Advanced Drug Delivery Reviews·Serguei V VinogradovAlexander V Kabanov
Jul 13, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Simone BraggioMarcella Petrone
Aug 29, 2002·Critical Reviews in Therapeutic Drug Carrier Systems·Patrick CouvreurChristine Vauthier
Sep 5, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Adriana Raffin PohlmannSílvia Stanisçuaski Guterres
Jul 25, 2003·International Journal of Pharmaceutics·Ying ChenJing Gao
Nov 22, 2005·Expert Opinion on Drug Delivery·Monjed ShakwehElias Fattal
Nov 25, 2005·Current Drug Delivery·Adriana Raffin PohlmannSílvia Stanis Uaski Guterres
Mar 1, 2006·International Journal of Pharmaceutics·Letícia CruzAdriana R Pohlmann
Oct 20, 2006·Journal of Nanoscience and Nanotechnology·Rubiana Mara MainardesRaul Cesar Evangelista
Nov 10, 2006·Advanced Drug Delivery Reviews·Vladimir P Torchilin
Mar 3, 2007·International Journal of Pharmaceutics·Alessando JägerAdriana R Pohlmann
Aug 6, 2008·International Journal of Pharmaceutics·Vitória B CattaniTeresa Dalla Costa
May 9, 2009·British Journal of Pharmacology·A BernardiA M O Battastini
Jan 9, 2010·Journal of Biomedical Nanotechnology·Eliézer JägerAdriana R Pohlmann

❮ Previous
Next ❯

Citations

Oct 8, 2014·Nanoscale Research Letters·Tokuyuki YoshidaYasuo Tsutsumi
Feb 8, 2013·Expert Opinion on Drug Delivery·Adriana Raffin PohlmannSilvia S Guterres
Dec 21, 2013·Journal of Pharmaceutical Sciences·Ana-Maria VasiLiliana Verestiuc
Dec 19, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Thiane Deprá de SouzaMarcos Antonio Villetti
Feb 9, 2012·The Journal of Pharmacy and Pharmacology·Mohd Aftab AlamAbdullah M Al-Mohizea
Feb 3, 2015·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Luiza A FrankSilvia S Guterres
Sep 4, 2013·Pharmaceutical Development and Technology·Sandra Elisa HaasTeresa Dalla Costa
Jun 27, 2012·International Journal of Pharmaceutics·Dandan ZhengQiang Zhang
May 7, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rachel P BulcãoSolange C Garcia
Aug 22, 2016·Advanced Drug Delivery Reviews·Silvia Gabriella CiappellanoFederico Benetti
May 20, 2017·Pharmaceutical Development and Technology·Natháli S PegoraroLetícia Cruz
Feb 3, 2021·Drug Delivery and Translational Research·María Plaza-OliverMaría Victoria Lozano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

International Journal of Pharmaceutics
Letícia CruzAdriana R Pohlmann
International Journal of Pharmaceutics
Vitória B CattaniTeresa Dalla Costa
© 2022 Meta ULC. All rights reserved